Practice Point | Published:

Oral versus parenteral administration of methotrexate for the treatment of active RA

Nature Clinical Practice Rheumatology volume 4, pages 342343 (2008) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    and (2003) Low dose methotrexate and bone marrow suppression. BMJ 326: 266–267

  2. 2.

    et al. (1990) Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis. Arthritis Rheum 33: 91–94

  3. 3.

    et al. (1993) A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing. J Rheumatol 20: 1845–1849

  4. 4.

    et al. (2004) Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. J Rheumatol 31: 645–648

Download references

Acknowledgements

The synopsis was written by Lisa Richards, Editorial Assistant, Nature Clinical Practice.

Author information

Affiliations

  1. DJ Todd is a Rheumatology Fellow at the Brigham and Women's Hospital, and is affiliated with Harvard Medical School, Boston, MA, USA.

    • Derrick J Todd
  2. ME Weinblatt is Co-Director of Clinical Rheumatology at the Brigham and Women's Hospital and the John R and Eileen K Riedman Professor of Medicine at Harvard Medical School, Boston, MA, USA.

    • Michael E Weinblatt

Authors

  1. Search for Derrick J Todd in:

  2. Search for Michael E Weinblatt in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Michael E Weinblatt.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/ncprheum0827

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing